Celsense, Inc.

June 2, 2009 - Celsense Inc. reported it is one of the recipients in a four-year $1.95 million grant from the National Institutes of Health, funding to evaluate Cell Sense, the company’s fluorocarbon-based magnetic resonance imaging (MRI) cell tracking reagent, for clinical use.